0000899243-21-021408.txt : 20210601
0000899243-21-021408.hdr.sgml : 20210601
20210601192506
ACCESSION NUMBER: 0000899243-21-021408
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210528
FILED AS OF DATE: 20210601
DATE AS OF CHANGE: 20210601
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kornfeld Steven
CENTRAL INDEX KEY: 0001814653
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38052
FILM NUMBER: 21987130
MAIL ADDRESS:
STREET 1: C/O FORTE BIOSCIENCES, INC.
STREET 2: 1124 W. CARSON ST., MRL BLDG 3-320
CITY: TORRANCE
STATE: CA
ZIP: 90502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Forte Biosciences, Inc.
CENTRAL INDEX KEY: 0001419041
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261243872
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1124 W CARSON STREET
STREET 2: MRL BUILDING 3-320
CITY: TORRANCE
STATE: CA
ZIP: 90502
BUSINESS PHONE: (310) 618-6994
MAIL ADDRESS:
STREET 1: 1124 W CARSON STREET
STREET 2: MRL BUILDING 3-320
CITY: TORRANCE
STATE: CA
ZIP: 90502
FORMER COMPANY:
FORMER CONFORMED NAME: Tocagen Inc
DATE OF NAME CHANGE: 20071120
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-05-28
0
0001419041
Forte Biosciences, Inc.
FBRX
0001814653
Kornfeld Steven
C/O FORTE BIOSCIENCES, INC.
1124 W. CARSON STREET, MRL BLDG. 3-320
TORRANCE
CA
90502
1
0
0
0
Stock Option (right to buy)
35.54
2021-05-28
4
A
0
20000
0.00
A
2031-05-28
Common Stock
20000
20000
D
Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the twelve (12) months following the Date of Grant, provided that the shares subject to the option shall be fully vested on the date of the Issuer's next annual stockholder meeting. "Date of Grant" shall mean May 28, 2021.
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
2021-06-01